Clinical trials
Hospital Acquired Condition clinical trials
Below are recruiting hospital acquired condition clinical trials, each written for real people, not researchers. We’re tracking 30 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06359587Recruiting
Rethinking routine lab tests in BC hospitals
This study looks at how routine lab tests are ordered in certain hospital units. It involves both patients and healthcare providers in general internal medicine or family medicine (hospitalist) teams.
Prince George, British ColumbiaAges 18 years+ - NCT06791382Recruiting
AI infection risk study for hospital patients
This study uses an artificial intelligence system to analyze electronic health records and predict which hospital patients might develop an infection. If you join, your health data will be used to train the AI, which could help prevent infections in the future.
Wenzhou, ZhejiangAges birth–90 years - NCT05973916Recruiting
Hospital disinfection improvement for patients on two wards
This study tests a comprehensive approach to improve cleaning and disinfection in the hospital to reduce germs. You may be included if you are currently hospitalized on one of two specific medicine wards at the study hospital.
Be’er Ya‘aqovAges 18 years+ - NCT05725928Recruiting
Walking-support program for older hospitalized patients
This study tests whether extra help and guidance to walk while you’re in the hospital can improve health and recovery. It’s for older adults who can safely do some walking after being admitted for a medical problem.
Springfield, MassachusettsAges 65 years+ - NCT06326424Recruiting
Delirium check for older dementia patients in the ER
This study tests a way to identify delirium (sudden confusion) in older adults with Alzheimer's or other dementias while they are in the emergency room or hospital. It may help doctors detect and treat confusion faster.
Columbus, OhioAges 65 years+ - NCT07759934RecruitingPhase 2
Comparing ASK0912 to polymyxin B for hospital-acquired pneumonia
This study compares an experimental antibiotic called ASK0912 with an approved antibiotic (polymyxin B) in adults with hospital-acquired or ventilator-associated pneumonia. It aims to see if the new drug is as effective and safe as the standard treatment.
Nanjing, JiangsuAges 18 years+ - NCT07326540RecruitingPhase 3
Testing a new antibiotic for drug-resistant pneumonia in the hospital
This trial compares a new antibiotic (BV100 plus low-dose polymyxin B) against a standard treatment for pneumonia caused by a hard-to-treat bacteria (Acinetobacter baumannii). If you have hospital-acquired or ventilator-associated pneumonia and standard antibiotics aren't working, this study may offer a new option.
TbilisiAges 18–82 - NCT07303582RecruitingPhase 4
Freezing nerves to ease pain from muscle tightness
This study tests if freezing specific nerves (cryoneurolysis) can reduce pain caused by muscle tightness (spasticity) after a brain or spinal cord injury, or from multiple sclerosis. It is for people who already get Botox injections for this pain.
OxfordAges 18 years+ - NCT06611228Recruiting
Preventing disability in older hospital patients
This study tests if a program designed for older, frail hospital patients can prevent loss of ability to do daily tasks. It focuses on physical activity, mental engagement, and nutrition to help you stay independent.
Monza, LumbardyAges 70 years+ - NCT06087536RecruitingPhase 2
Trial of OMN6 for hospital-acquired Acinetobacter pneumonia
This trial tests a new antibiotic called OMN6 for people with a serious lung infection (pneumonia) caught in the hospital or from a breathing machine, caused by a hard-to-treat bacteria (Acinetobacter). The goal is to see if OMN6 is safe and how the body processes it.
AshdodAges 18–99 - NCT06841731RecruitingPhase 2
Testing a new antibiotic for hospital-acquired pneumonia
This trial tests a new antibiotic called HRS-8427 for adults with bacterial pneumonia that started in the hospital or while on a ventilator. It may be an option if you need IV antibiotics and haven't already received long-term treatment for this infection.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05979545RecruitingPhase 4
Early treatment with ceftazidime-avibactam for serious infections
This study tests an antibiotic called ceftazidime-avibactam for people with serious infections like bloodstream infections or pneumonia that started in the hospital or from a breathing machine. It aims to start treatment quickly after identifying the bacteria.
Kuala LumpurAges Any age - NCT07089186RecruitingPhase 3
Study of meropenem and pralurbactam for certain antibiotic-resistant infections
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
ShanghaiAges 18–80 - NCT07560696Recruiting
Web-based therapy for thinking and speech after illness
This study tests whether patients recovering from serious illness in the ICU or stroke ward can use a web-based platform called Cognishine to help rebuild their thinking skills and speech ability. The goal is to see if this online approach works well and is practical for patients receiving support from therapists.
LiverpoolAges 18 years+ - NCT05895032Recruiting
Exercise program for children with hemophilia A or B
This trial studies whether a structured exercise program helps children with hemophilia A or B safely. It looks at children’s ability to exercise and function, while aiming to avoid complications like leg bleeds or injuries.
Canterbury, KentAges 6–12 - NCT07150637Enrolling by invitation
Predicting muscle weakness in children on a breathing machine
This study aims to predict muscle weakness that can happen to children on breathing machines in the ICU. It could help doctors start treatments earlier to prevent this weakness.
Shanghai, Shanghai MunicipalityAges 1 month–18 years - NCT07150650Enrolling by invitation
Biomarkers for ICU weakness in children on breathing machines
This study looks for early warning signs (biomarkers) of muscle weakness that can happen in children who need a breathing machine for more than a few days. If your child is in the PICU on a ventilator for at least 3 days, this team may be able to test for clues that help prevent or manage this weakness.
Shanghai, Shanghai MunicipalityAges 1 month–18 years - NCT06800040Enrolling by invitation
Group memory training for brain injury survivors
This trial tests a group memory training program for people who have had a brain injury at least 6 months ago and still have memory problems. The training is in Norwegian and aims to help improve memory skills.
TromsøAges 18–75 - NCT05849740RecruitingPhase 4
CD38 antibody plus steroid for acquired hemophilia A
This trial studies whether a CD38-targeting antibody together with corticosteroids can improve outcomes in acquired hemophilia A. It is an “exploratory” Phase 4 study, meaning the goal is to learn more about safety and effectiveness in real-world patients.
TianjinAges 18 years+ - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT07708246Recruiting
Parent-led social skills program for children with autism
This trial tests whether a parent-led program can help children with autism improve social understanding. If you join, you will learn to use play-based activities at home with your child, with support from a clinician.
Shanghai, Shanghai MunicipalityAges 4–8 - NCT07448103Recruiting
Robot-assisted rehab for kids with brain injury
This trial uses a social robot and artificial intelligence to help children with acquired brain injury do rehabilitation exercises at the hospital or at home. The robot guides them through arm and hand activities to improve movement and recovery.
Madrid, MadridAges 7–16 - NCT05457569Recruiting
Parent support program for babies at high brain risk
This study checks whether a coordinated parent support program delivered after NICU (and after discharge) is practical and helpful. It gathers feedback through interviews with parents and professionals to improve how care and parenting support are organized.
DijonAges 18 years+ - NCT06794008RecruitingPhase 2
CAR-T cell therapy for hard-to-treat autoimmune diseases
This trial tests a new treatment using your own immune cells (called CAR-T cells) designed to target and attack cells that cause autoimmune diseases. It is for people with lupus, Sjögren's syndrome, inflammatory myopathy, scleroderma, Behcet's disease, ANCA-associated vasculitis, IgG4-related disease, antiphospholipid syndrome, or thrombotic thrombocytopenic purpura who have not improved with standard therapies.
Beijing, Beijing MunicipalityAges 18–65
Hear when a new Hospital Acquired Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospital acquired condition?
- Yes. Clin2 currently lists 30 recruiting hospital acquired condition studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospital acquired condition trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospital acquired condition trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.